Showing 1 - 20 results of 44 for search 'Francisco Abad Santos', query time: 0.06s
Refine Results
-
1
Association Studies in Clinical Pharmacogenetics by Pablo Zubiaur, Francisco Abad-Santos
Published 2022-12-01
Article -
2
Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis by Mónica Valdés-Garicano, Gina Mejía-Abril, Diana Campodónico, Raúl Parra-Garcés, Francisco Abad-Santos, Francisco Abad-Santos
Published 2022-07-01
Article -
3
-
4
Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism by Gina Mejía-Abril, Gina Mejía-Abril, Pablo Zubiaur, Pablo Zubiaur, Marcos Navares-Gómez, Gonzalo Villapalos-García, Manuel Román, Manuel Román, Dolores Ochoa, Dolores Ochoa, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos
Published 2021-04-01
Article -
5
Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin by Gonzalo Villapalos-García, Pablo Zubiaur, Marcos Navares-Gómez, Miriam Saiz-Rodríguez, Gina Mejía-Abril, Samuel Martín-Vílchez, Manuel Román, Manuel Román, Dolores Ochoa, Dolores Ochoa, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos
Published 2021-10-01
Article -
6
-
7
-
8
The Pharmacogenetics of Treatment with Quetiapine by María Ortega-Ruiz, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Francisco Abad-Santos, Pablo Zubiaur
Published 2022-07-01
Article -
9
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a... by Rosario Garcia-Vicuña, Francisco Abad-Santos, Isidoro González-Alvaro, Francisco Ramos-Lima, Jesús Sanz Sanz
Published 2020-09-01
Article -
10
High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects by Dolores Ochoa, Dolores Ochoa, Miriam Saiz-Rodríguez, Miriam Saiz-Rodríguez, Esperanza González-Rojano, Manuel Román, Manuel Román, Sergio Sánchez-Rojas, Aneta Wojnicz, Ana Ruiz-Nuño, Alfredo García-Arieta, Francisco Abad-Santos, Francisco Abad-Santos
Published 2021-04-01
Article -
11
Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine by Sofía Calleja, Pablo Zubiaur, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Gina Mejia-Abril, Paula Soria-Chacartegui, Marcos Navares-Gómez, Alejandro de Miguel, Manuel Román, Samuel Martín-Vílchez, Francisco Abad-Santos, Francisco Abad-Santos
Published 2023-02-01
Article -
12
-
13
-
14
Preemptive <i>TPMT</i> Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for... by Sarahí Valdez-Acosta, Pablo Zubiaur, Miguel Angel Casado, Jesús Novalbos, Ana Casajús, Diana Campodónico, Itziar Oyagüez, Francisco Abad-Santos
Published 2023-07-01
Article -
15
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke by Macarena Hernández-Jiménez, Francisco Abad-Santos, Francisco Abad-Santos, Ian Cotgreave, Jaime Gallego, Bernd Jilma, Alan Flores, Tudor G. Jovin, José Vivancos, Carlos A. Molina, Joan Montaner, Joaquín Casariego, Mads Dalsgaard, María Hernández-Pérez, David S. Liebeskind, Erik Cobo, Marc Ribo, Marc Ribo
Published 2023-02-01
Article -
16
-
17
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives by Álvaro Pinto-Merino, Jorge Labrador, Pablo Zubiaur, Raquel Alcaraz, María José Herrero, Pau Montesinos, Francisco Abad-Santos, Miriam Saiz-Rodríguez
Published 2022-03-01
Article -
18
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study by Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A. López-Fernández, Marcos Navares-Gómez, Gina Mejía-Abril, Francisco Abad-Santos, Pablo Zubiaur
Published 2021-11-01
Article -
19
Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial by Rosario García-Vicuña, Rosario García-Vicuña, Sebastián C. Rodriguez-García, Francisco Abad-Santos, Francisco Abad-Santos, Azucena Bautista Hernández, Lucio García-Fraile, Ana Barrios Blandino, Angela Gutiérrez Liarte, Tamara Alonso-Pérez, Laura Cardeñoso, Aránzazu Alfranca, Aránzazu Alfranca, Gina Mejía-Abril, Jesús Sanz Sanz, Isidoro González-Alvaro
Published 2022-02-01
Article -
20